default author photo

Xin Mei

Fudan University - Department of Radiation Oncology

SCHOLARLY PAPERS

2

DOWNLOADS

74

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Reappraising Radiotherapy in Node‐Negative Breast Cancer: Insights from an EORTC 22922/10925–Matched Cohort in the Modern Systemic Therapy Era

Number of pages: 20 Posted: 22 Jul 2025
Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Breast Surgery, Fudan University - Department of Radiation Oncology and Fudan University - Department of Radiation Oncology
Downloads 51 (1,052,702)

Abstract:

Loading...

breast cancer, radiotherapy, node negative, EORTC 22922/10925, survival

2.

Impact of HER2-low and predictive model for locoregional recurrence in breast cancer patients after postoperative radiotherapy

Number of pages: 31 Posted: 24 Oct 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, Fudan University - Department of Radiation Oncology, affiliation not provided to SSRN, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, affiliation not provided to SSRN, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology and Fudan University - Department of Radiation Oncology
Downloads 23 (1,411,822)

Abstract:

Loading...

HER2-low, locoregional recurrence, radiotherapy, predictive model, breast cancer